- May 6, 2020
MADISON, WI–Nimble Therapeutics, Inc. today announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro
300 Montgomery Street
Suite 1130
San Francisco, CA 94104